Elixinol Wellness (EXL) Stock Price, News & Analysis

Company Overview

Elixinol Wellness Limited is a pioneer in the global hemp industry, innovating, marketing and selling hemp and other plant-derived nutraceutical, cosmetic and food products.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$8.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:EXL
• CIK: N/A
• Web: www.elixinolglobal.com
• Phone: 61 2 4044 4585
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$6.87 million
• Net Margins: -59.27%
• Pretax Margin: N/A
• Return on Equity: -98.83%
• Return on Assets: -28.12%

Debt

• Debt-to-Equity Ratio: 15.90
• Current Ratio: 1.81
• Quick Ratio: 2.80

Sales & Book Value

• Annual Sales: A$11.59 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,320,000,000
• Free Float: N/A
• Market Cap: A$8.17 million
• Optionable: Not Optionable
• Beta: 2.23